Mendus AB (CHIX:IMMUS) Other Current Liabilities : kr13.38 Mil (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Mendus AB Other Current Liabilities?

Mendus AB's other current liabilities for the quarter that ended in Mar. 2024 was kr13.38 Mil.

Mendus AB's quarterly other current liabilities increased from Sep. 2023 (kr14.15 Mil) to Dec. 2023 (kr17.05 Mil) but then declined from Dec. 2023 (kr17.05 Mil) to Mar. 2024 (kr13.38 Mil).

Mendus AB's annual other current liabilities increased from Dec. 2021 (kr14.13 Mil) to Dec. 2022 (kr18.41 Mil) but then declined from Dec. 2022 (kr18.41 Mil) to Dec. 2023 (kr17.05 Mil).

Mendus AB Other Current Liabilities Historical Data

The historical data trend for Mendus AB's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mendus AB Other Current Liabilities Chart

Mendus AB Annual Data

Trend

Jun14

Jun15

Jun16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Current Liabilities

Get a 7-Day Free Trial

Mendus AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Current Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Mendus AB Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Mendus AB Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Mendus AB's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Mendus AB (CHIX:IMMUS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mendus AB (CHIX:IMMUs) » Definitions » Other Current Liabilities

Comparable Companies

Traded in Other Exchanges

IMMU:Sweden 1YG:Germany

Address

Vastra Tradgardsgatan 15, Stockholm, SWE, 11153

Website

https://www.mendus.com

Mendus AB is a clinical-level biopharmaceutical company that focuses on the development of immunotherapies that address tumor recurrence and difficult-to-treat established tumors. Its operations consist of research and development for pharmaceuticals.

Mendus AB (CHIX:IMMUS) Headlines

No Headlines